- Home
- RBOT vs AVTX Comparison
RBOT vs AVTX Comparison
Compare RBOT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- AVTX
- Stock Information
- Founded
- RBOT 2014
- AVTX 2011
- Country
- RBOT United States
- AVTX United States
- Employees
- RBOT N/A
- AVTX N/A
- Industry
- RBOT Medical Specialities
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- RBOT Health Care
- AVTX Health Care
- Exchange
- RBOT Nasdaq
- AVTX Nasdaq
- Market Cap
- RBOT 38.2M
- AVTX 248.3M
- IPO Year
- RBOT N/A
- AVTX 2015
- Fundamental
- Price
- RBOT $5.64
- AVTX $13.69
- Analyst Decision
- RBOT Hold
- AVTX Strong Buy
- Analyst Count
- RBOT 1
- AVTX 9
- Target Price
- RBOT $7.00
- AVTX $30.14
- AVG Volume (30 Days)
- RBOT 102.5K
- AVTX 505.6K
- Earning Date
- RBOT 11-11-2025
- AVTX 11-06-2025
- Dividend Yield
- RBOT N/A
- AVTX N/A
- EPS Growth
- RBOT N/A
- AVTX N/A
- EPS
- RBOT N/A
- AVTX N/A
- Revenue
- RBOT N/A
- AVTX $441,000.00
- Revenue This Year
- RBOT N/A
- AVTX N/A
- Revenue Next Year
- RBOT N/A
- AVTX N/A
- P/E Ratio
- RBOT N/A
- AVTX N/A
- Revenue Growth
- RBOT N/A
- AVTX N/A
- 52 Week Low
- RBOT $5.00
- AVTX $3.39
- 52 Week High
- RBOT $19.00
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- RBOT 43.07
- AVTX 60.05
- Support Level
- RBOT $5.83
- AVTX $13.42
- Resistance Level
- RBOT $7.45
- AVTX $15.99
- Average True Range (ATR)
- RBOT 0.71
- AVTX 1.20
- MACD
- RBOT 0.08
- AVTX 0.06
- Stochastic Oscillator
- RBOT 15.76
- AVTX 56.16
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).